Vahid Saadat

Vahid Saadat

Director Ejecutivo en Inquis Medical, Inc. .

Health Technology
Health Services
Consumer Services

Perfil

Vahid C.
Saadat
is the founder.
He founded Voyage Medical, Inc. in 2006, Baxano, Inc. in 2005, USGI Medical, Inc. in 2001, and Inquis Medical, Inc. in 2019.
At Voyage Medical, Inc., he held the title of President, Chief Executive Officer & Director in 2011.
At Baxano, Inc., he was a Director from 2010 to 2013.
At USGI Medical, Inc., he was the President.
Currently, Mr. Saadat is a Venture Partner at Yu Galaxy LLC since 2020.
In his former positions, he was the President & Chief Executive Officer at Angiotrax, Inc., the Chief Executive Officer at Arrinex, Inc. from 2014 to 2019, and the Senior Vice President-Research & Development at Trimedyne, Inc. He also served as the Vice President-Research & Development at Gynecare, Inc. Mr. Saadat obtained his undergraduate degree in 1984 and his graduate degree in 1986 from The University of Texas at Austin.

Cargos activos de Vahid Saadat

EmpresasCargoInicio
Inversor de Capital Privado 01/12/2020
Director Ejecutivo 01/10/2019
Todos los cargos activos de Vahid Saadat

Antiguos cargos conocidos de Vahid Saadat.

EmpresasCargoFin
Director Ejecutivo 01/02/2019
Fundador 03/06/2013
Gynecare, Inc. Director Técnico/Científico/I+D -
Angiotrax, Inc. Director Ejecutivo -
TRIMEDYNE, INC. Director de Operaciones -
Ver el detalle de la experiencia de Vahid Saadat.

Formación de Vahid Saadat.

The University of Texas at Austin Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Vahid Saadat.

Relaciones

24

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas9

Health Technology

Health Services

Health Technology

Health Technology

Gynecare, Inc.

Angiotrax, Inc.

Health Technology

Finance

Health Technology

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA